Hormonal contraception
| Errataetall: |
CommentIn: N Engl J Med. 1993 Nov 11;329(20):1501-2. - PMID 8292164 |
|---|---|
| Medienart: |
Artikel |
| Erscheinungsjahr: |
1993 |
|---|---|
| Erschienen: |
1993 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:328 |
|---|---|
| Enthalten in: |
The New England journal of medicine - 328(1993), 21 vom: 27. Mai, Seite 1543-9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Baird, D T [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 27.05.1993 Date Revised 16.11.2005 published: Print CommentIn: N Engl J Med. 1993 Nov 11;329(20):1501-2. - PMID 8292164 Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM08454080X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM08454080X | ||
| 003 | DE-627 | ||
| 005 | 20231222061514.0 | ||
| 007 | tu | ||
| 008 | 231222s1993 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0282.xml |
| 035 | |a (DE-627)NLM08454080X | ||
| 035 | |a (NLM)8479492 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Baird, D T |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hormonal contraception |
| 264 | 1 | |c 1993 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 27.05.1993 | ||
| 500 | |a Date Revised 16.11.2005 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: N Engl J Med. 1993 Nov 11;329(20):1501-2. - PMID 8292164 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Biology | |
| 650 | 4 | |a Cancer--women | |
| 650 | 4 | |a Carbohydrate Metabolic Effects | |
| 650 | 4 | |a Cardiovascular Effects | |
| 650 | 4 | |a Contraception | |
| 650 | 4 | |a Contraceptive Agents | |
| 650 | 4 | |a Contraceptive Agents, Female | |
| 650 | 4 | |a Contraceptive Agents, Postcoital | |
| 650 | 4 | |a Contraceptive Agents, Progestin | |
| 650 | 4 | |a Contraceptive Implants | |
| 650 | 4 | |a Contraceptive Methods--side effects | |
| 650 | 4 | |a Diseases | |
| 650 | 4 | |a Endocrine System | |
| 650 | 4 | |a Family Planning | |
| 650 | 4 | |a Hormone Antagonists | |
| 650 | 4 | |a Hormones | |
| 650 | 4 | |a Hypertension | |
| 650 | 4 | |a Iud | |
| 650 | 4 | |a Iud, Hormone Releasing | |
| 650 | 4 | |a Levonorgestrel | |
| 650 | 4 | |a Lipid Metabolic Effects | |
| 650 | 4 | |a Lipids | |
| 650 | 4 | |a Literature Review | |
| 650 | 4 | |a Male Contraception | |
| 650 | 4 | |a Metabolic Effects | |
| 650 | 4 | |a Neoplasms | |
| 650 | 4 | |a Oral Contraceptives, Combined--side effects | |
| 650 | 4 | |a Oral Contraceptives--side effects | |
| 650 | 4 | |a Physiology | |
| 650 | 4 | |a Vaginal Rings | |
| 650 | 4 | |a Vascular Diseases | |
| 650 | 7 | |a Contraceptive Agents, Male |2 NLM | |
| 650 | 7 | |a Contraceptives, Oral, Combined |2 NLM | |
| 650 | 7 | |a Contraceptives, Oral, Hormonal |2 NLM | |
| 650 | 7 | |a Contraceptives, Postcoital |2 NLM | |
| 650 | 7 | |a Drug Implants |2 NLM | |
| 650 | 7 | |a Progestins |2 NLM | |
| 700 | 1 | |a Glasier, A F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d 1945 |g 328(1993), 21 vom: 27. Mai, Seite 1543-9 |w (DE-627)NLM000008184 |x 1533-4406 |7 nnns |
| 773 | 1 | 8 | |g volume:328 |g year:1993 |g number:21 |g day:27 |g month:05 |g pages:1543-9 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 328 |j 1993 |e 21 |b 27 |c 05 |h 1543-9 | ||